Announcements Trials
Browse Landscape

Clinical Trials

6 trials
RecentStart dateEnrollment
AGuIX × Clear all

Phase

Phase 2 2Phase 1/2 2Phase 1 2

Status

Unknown 2Terminated 1Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 6

Study Type

Interventional 6

Sponsor

Cancer Type

CNS 4Thoracic 1Gynecologic 1

Conditions

Brain Neoplasms 3Gynecologic Cancer 1Glioblastoma 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 3180Cyclophosphamide 3173Carboplatin 2960Radiotherapy 2772Paclitaxel 2708Gemcitabine 2552pembrolizumab 2370Bevacizumab 2195Docetaxel 2191Fluorouracil 1839Capecitabine 1815Oxaliplatin 1724Dexamethasone 1593Nivolumab 1577Doxorubicin 1501Rituximab 1480Magnetic Resonance Spectroscopy 1368Etoposide 1344Irinotecan 1241Leucovorin 1217Drug Therapy 1190Cytarabine 1127Pemetrexed 1068fludarabine 1035Specimen Handling 987Vincristine 964Prednisone 940Cetuximab 939Trastuzumab 937Lenalidomide 932

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements
NCT04789486 2025-05-23

Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer

Dana-Farber Cancer Institute

Phase 1/2 Recruiting
100 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04881032 2025-02-13

NANO-GBM

Centre Jean Perrin

Phase 1/2 Active not recruiting
66 enrolled
CNS

Glioblastoma

NCT03818386 2024-06-14

NANORAD2

University Hospital, Grenoble

Phase 2 Unknown
100 enrolled
CNS

Brain Neoplasms

NCT03308604 2021-07-07

NANOCOL

Gustave Roussy, Cancer Campus, Grand Paris

Phase 1 Unknown
18 enrolled
Gynecologic

Gynecologic Cancer

NCT04094077 2021-06-08

NANOSTEREO

Centre Leon Berard

Phase 2 Terminated
1 enrolled
CNS

Brain Neoplasms

NCT02820454 2019-06-07

NANO-RAD

University Hospital, Grenoble

Phase 1 Completed
15 enrolled
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡